4.1 Review

Atherosclerosis and Thrombosis: Insights from Large Animal Models

期刊

出版社

HINDAWI LTD
DOI: 10.1155/2011/907575

关键词

-

资金

  1. Spanish Ministry of Science [PNS 2006-10091]
  2. Lilly Foundation [CIBER OBN06, FIS PI071070, REDINSCOR RD06/0003/0015]
  3. Spanish Ministry of Science and Innovation (RyC, MICINN)

向作者/读者索取更多资源

Atherosclerosis and its thrombotic complications are responsible for remarkably high numbers of deaths. The combination of in vitro, ex vivo, and in vivo experimental approaches has largely contributed to a better understanding of the mechanisms underlying the atherothrombotic process. Indeed, different animal models have been implemented in atherosclerosis and thrombosis research in order to provide new insights into the mechanisms that have already been outlined in isolated cells and protein studies. Yet, although no model completely mimics the human pathology, large animal models have demonstrated better suitability for translation to humans. Indeed, direct translation from mice to humans should be taken with caution because of the well-reported species-related differences. This paper provides an overview of the available atherothrombotic-like animal models, with a particular focus on large animal models of thrombosis and atherosclerosis, and examines their applicability for translational research purposes as well as highlights species-related differences with humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles

Sean M. Davidson, Chantal M. Boulanger, Elena Aikawa, Lina Badimon, Lucio Barile, Christoph J. Binder, Alain Brisson, Edit Buzas, Costanza Emanueli, Felix Jansen, Miroslava Katsur, Romaric Lacroix, Sai Kiang Lim, Nigel Mackman, Manuel Mayr, Philippe Menasche, Rienk Nieuwland, Susmita Sahoo, Kaloyan Takov, Thomas Thum, Pieter Vader, Marca H. M. Wauben, Kenneth Witwer, Joost P. G. Sluijter

Summary: This article provides an overview of the techniques and technologies available for the separation and characterization of EVs from different sources. It discusses methods for determining the protein, RNA, and lipid content of EVs. The guidance provided in this document is important for investigating the role of EVs in cardiovascular diseases and highlights key methodological issues to consider.

CARDIOVASCULAR RESEARCH (2023)

Review Cardiac & Cardiovascular Systems

Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality

Frank Lezoualc'h, Lina Badimon, Hana Baker, Monique Bernard, Gabor Czibik, Rudolf A. de Boer, Thomas D'Humieres, Micheline Kergoat, Mark Kowala, Jennifer Rieusset, Gemma Vilahur, Maximin Detrait, Chris Watson, Genevieve A. Derumeaux

Summary: Diabetic cardiomyopathy is a distinct, multifactorial disease that leads to ventricular hypertrophy and abnormal myocardial contractility. Animal models provide opportunities to study its mechanisms, but there are limitations when extrapolating findings to humans.

CARDIOVASCULAR RESEARCH (2023)

Editorial Material Cardiac & Cardiovascular Systems

The unknown functions of a known protein: the case of coagulation factor XI

Emiel P. C. van der Vorst, Lina Badimon

CARDIOVASCULAR RESEARCH (2023)

Editorial Material Cardiac & Cardiovascular Systems

Statins revisited: therapeutic applications beyond lipid lowering?

Lina Badimon, Guiomar Mendieta, Gemma Vilahur

EUROPEAN HEART JOURNAL (2023)

Article Medicine, General & Internal

Dysfunctional antioxidant capacity of high-density lipoprotein in rheumatoid arthritis

Maria Carmen Garcia-Gomez, Teresa Padro, Natalia Munoz-Garcia, Maria Bianchi, Lorenzo Alvarez, Lina Badimon, Emili Corbella, Xavier Pinto

Summary: This study investigated the HDL antioxidant function in patients with rheumatoid arthritis (RA). The results showed that RA patients had lower HDL antioxidant capacity and a lower resistance of LDL particles to oxidation, mainly related to the degree of inflammation.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Biochemistry & Molecular Biology

HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS

Alberto Cordero, Natalia Munoz-Garcia, Teresa Padro, Gemma Vilahur, Vicente Bertomeu-Gonzalez, David Escribano, Emilio Flores, Pilar Zuazola, Lina Badimon

Summary: This study investigated the role of lipoprotein functionality as well as particle number and size in patients with acute coronary syndrome (ACS) and on-target LDL-C levels. It was found that ACS patients had higher susceptibility to LDL oxidation and lower HDL-antioxidant capacity. They also had lower HDL-C and Apolipoprotein A-I levels compared to non-ACS patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Effects of Antioxidants in Fermented Beverages in Tissue Transcriptomics: Effect of Beer Intake on Myocardial Tissue after Oxidative Injury

Alex Gallinat, Gemma Vilahur, Teresa Padro, Lina Badimon

Summary: This study analyzed the effects of beer consumption on the gene expression response of the heart under oxidative stress, and found that beer intake can regulate gene expression in the heart and have a protective effect. It was also found that different doses of beer intake have different effects.

ANTIOXIDANTS (2023)

Article Cardiac & Cardiovascular Systems

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Jeanine E. Roeters van Lennep, Lale S. Tokgozoglu, Lina Badimon, Sandra M. Dumanski, Martha Gulati, Connie N. Hess, Kirsten B. Holven, Maryam Kavousi, Meral Kayikcioglu, Esther Lutgens, Erin D. Michos, Eva Prescott, Jane K. Stock, Anne Tybjaerg-Hansen, Marieke J. H. Wermer, Marianne Benn

Summary: Cardiovascular disease is the leading cause of death globally, with atherosclerotic cardiovascular disease (ASCVD) being the main contributor. ASCVD mortality is currently increasing, especially in middle-aged women. Sex-specific factors, such as hypertensive disorders of pregnancy, premature menopause, and polycystic ovary syndrome, are associated with higher cardiovascular risk.

EUROPEAN HEART JOURNAL (2023)

Article Biochemistry & Molecular Biology

Red Blood Cells and Endothelium Derived Circulating Extracellular Vesicles in Health and Chronic Heart Failure: A Focus on Phosphatidylserine Dynamics in Vesiculation

Rosa Suades, Alba Vilella-Figuerola, Teresa Padro, Sonia Mirabet, Lina Badimon

Summary: In this study, circulating extracellular microvesicles (cEVs) from chronic heart failure patients were phenotypically and quantitatively characterized. It was found that PS--cEVs were predominantly present in both chronic heart failure patients and non-HF subjects, but the proportions of PS-cEVs varied depending on the parental markers. PS+-cEVs were mainly derived from platelets and increased in the non-HF group, while PS--cEVs were mainly derived from endothelium and connexin 43-rich sources and significantly increased in chronic heart failure patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease

Maria Bergami, Olivia Manfrini, Stefano Nava, Gaetano Caramori, Jinsung Yoon, Lina Badimon, Edina Cenko, Antonio David, Ilir Demiri, Maria Dorobantu, Natalia Fabin, Oana Gheorghe-Fronea, Radmilo Jankovic, Sasko Kedev, Nebojsa Ladjevic, Ratko Lasica, Goran Loncar, Giuseppe Mancuso, Guiomar Mendieta, Davor Milicic, Petra Mjehovic, Marijan Pasalic, Milovan Petrovic, Lidija Poposka, Marialuisa Scarpone, Milena Stefanovic, Mihaela van der Schaar, Zorana Vasiljevic, Marija Vavlukis, Maria Laura Vega Pittao, Vladan Vukomanovic, Marija Zdravkovic, Raffaele Bugiardini

Summary: This study found that the use of azithromycin in COVID-19 patients with prior history of cardiovascular disease is significantly associated with an increased risk of acute heart failure and all-cause 30-day mortality. However, in patients without prior cardiovascular disease, azithromycin treatment is associated with significantly reduced risk of death and no significant increase in acute heart failure.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Medical Laboratory Technology

A Novel ELISA for the Quantification of Serum Levels of 2 Glycosylated Variants of Apolipoprotein J: Biomarkers for Myocardial Ischemia

Lola Fernandez Encinas, Nuria Lluch, Alan H. B. Wu, Juan Carlos Kaski, Lina Badimon, Judit Cubedo

Summary: This study aimed to validate the analytical performance of two novel ELISAs for two different glycosylated ApoJ variants (ApoJ-GlycA2 and ApoJ-GlycA6). The results showed that these methods fulfilled the acceptance criteria established by the European Medicines Agency for precision, accuracy, recovery, cross-reactivity, and stability. These newly developed ELISAs accurately measured serum levels of ApoJ-GlycA2 and ApoJ-GlycA6.

JOURNAL OF APPLIED LABORATORY MEDICINE (2023)

Review Biochemistry & Molecular Biology

Adipose-Derived Stem Cells to Treat Ischemic Diseases: The Case of Peripheral Artery Disease

Gemma Arderiu, Anna Civit-Urgell, Lina Badimon

Summary: The incidence and prevalence of critical limb ischemia have increased, but there are no successful treatments available. Adipose-derived stem cells (ASCs) are a promising source of stem cells for cell-based therapy due to their multilineage capacity and low immunogenicity. The proangiogenic benefits of ASCs are attributed to their secretion of proangiogenic molecules, microvesicles/exosomes, and their differentiation capability toward endothelial cells (ECs). However, the therapeutic efficacy of ASCs in peripheral artery diseases patients is still relatively low.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Jeanine E. Roeters van Lennep, Lale S. Tokgozoglu, Lina Badimon, Sandra M. Dumanski, Martha Gulati, Connie N. Hess, Kirsten B. Holven, Maryam Kavousi, Meral Kayikcioglu, Esther Lutgens, Erin D. Michos, Eva Prescott, Jane K. Stock, Anne Tybjaerg-Hansen, Marieke J. H. Wermer, Marianne Benn

Summary: Cardiovascular disease is the leading cause of death globally, with women experiencing the fastest relative increase in middle-aged mortality. In addition to missed or delayed diagnosis and undertreatment, sex-specific factors contribute to increased cardiovascular risk in women. The European Atherosclerosis Society's position statement focuses on the impact of gender-specific factors and the effects of these factors on women's lifelong lipid profiles, including lipoprotein(a). Sociocultural components further compound these effects. Early identification and treatment of modifiable cardiovascular risk factors in women, especially those related to sex-specific conditions, are necessary to reduce the high burden of cardiovascular disease in women.

EUROPEAN HEART JOURNAL (2023)

暂无数据